Is gabapentin a sedative? Understanding its sedating effects

The BNF lists gabapentin as an anti-epileptic (antiseizure) medicine. Doctors also prescribe it widely for neuropathic pain, which is nerve pain. It is not a sedative or a sleeping tablet.

In practice, though, this label matters less than the pharmacology textbooks suggest. Gabapentin makes many people feel very drowsy.

Sedation is one of its most often reported side effects.

What gabapentin is licensed for in the UK:

• Epilepsy: as an add-on treatment for focal seizures, with or without secondary generalisation
• Neuropathic pain: peripheral neuropathic pain in adults

Off-label uses (not formally licensed, but often prescribed):

• Generalised anxiety disorder
• Migraine prevention
• Restless legs syndrome
• Insomnia, mainly when it is linked to pain
• Support during alcohol withdrawal

Since April 2019, gabapentin has been a Schedule 3 controlled substance in the UK under the Misuse of Drugs Regulations. This reflects worries about misuse and the risk of dependence.

The name suggests a link with GABA (gamma-aminobutyric acid), a calming brain chemical. Yet gabapentin does not bind directly to GABA receptors. Its calming effect comes from a different route.

Primary mechanism:

Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, which is the brain and spinal cord.

This lowers the amount of calcium that flows into nerve endings. As a result, nerves release fewer excitatory messengers, such as glutamate, noradrenaline and substance P.

How this causes sedation:

• With less excitatory signalling, the nervous system feels calmer overall
• Less noradrenaline release adds to relaxation and drowsiness
• The effect on thalamocortical circuits, the brain pathways that control wakefulness, may help sleep

Comparison with true sedatives:

• Benzodiazepines (for example diazepam) boost GABA-A receptor activity directly. This gives fast, strong sedation
• Z-drugs (for example zopiclone) also act on GABA-A receptors, at the benzodiazepine binding site
• Gabapentin works in an indirect way. It gives a gentler sedation that many people call a "calming" effect rather than a "knockout" one

This difference in how the drugs work matters in the clinic. Gabapentin's sedation is usually milder than that of benzodiazepines.

On its own, it also has a lower risk of slowed breathing (respiratory depression), though the risk is not zero.

Sedation is often listed as an unwanted side effect. Even so, gabapentin's calming effect can sometimes be useful as a treatment.

Sleep disturbance in chronic pain:

People with neuropathic pain often sleep badly. Gabapentin can ease both the pain and the poor sleep at the same time. Taking the larger part of the daily dose at bedtime can improve sleep.

This may avoid the need for a separate sleeping tablet.

Anxiety-related insomnia:

Gabapentin is sometimes used off-label for generalised anxiety. Its calming effect can help people who cannot sleep because they feel anxious.

Pre-operative anxiety:

Some anaesthetists give gabapentin as a pre-medication before surgery. It can reduce anxiety and improve pain control after the operation. Its calming effect is part of why it helps here.

Alcohol withdrawal:

During alcohol withdrawal, people often have insomnia, anxiety and agitation. Gabapentin can calm and ease anxiety, so it may help as part of a detox plan.

Important considerations:

• Sedation should be a welcome effect, not just one you put up with. If drowsiness gets in the way of daily life, speak to your prescriber
• The calming effect tends to fade with continued use, as your body builds tolerance
• NICE does not recommend gabapentin as a first-choice treatment for insomnia on its own

Sometimes gabapentin's drowsiness is a nuisance rather than a help. If so, there are several things you can try.

Dose and timing adjustments:

• Move more of the dose to bedtime: if you take gabapentin three times daily, ask your prescriber about a smaller morning dose and a larger evening dose
• Slow titration: raising the dose more slowly gives your body time to adjust. The BNF recommends increasing the dose gradually
• Dose reduction: if sedation is severe, a lower total daily dose may still control your pain or seizures well, with less drowsiness

Lifestyle measures:

• Avoid other things that make you drowsy, including alcohol, antihistamines and over-the-counter sleep aids
• Keep a regular sleep-wake routine to cut daytime drowsiness
• Stay active during the day, as exercise can fight off fatigue
• Drink caffeine only in the morning

When to review treatment:

• If sedation lasts beyond the first 2 to 4 weeks at a steady dose
• If drowsiness affects your work, driving or quality of life
• If you also take opioids or benzodiazepines (discuss this combination urgently with your prescriber)

Other medicines for neuropathic pain, such as amitriptyline or duloxetine, cause different side effects. Some people tolerate them better.

NICE guidance on neuropathic pain says to try an alternative if the first choice does not suit you.

Pregabalin (Lyrica) works in a similar way to gabapentin and also causes sedation. Many patients and prescribers ask how the two compare.

Key differences:

• Pregabalin is absorbed more reliably. About 90% reaches the bloodstream, compared with gabapentin's variable 30-60%. Its dose-response is also more predictable
• Pregabalin tends to cause more steady sedation at treatment doses
• Gabapentin's absorption is saturable. This means higher doses do not always give proportionally bigger effects, including sedation
• Both are Schedule 3 controlled substances in the UK

Clinical implications:

• If you find gabapentin too sedating, pregabalin may not suit you any better, because both work the same way
• The other way round, if you tolerate gabapentin well, you may find pregabalin more sedating
• Switching between the two should be done under medical supervision, with a slow cross-titration

What the evidence says:

NICE does not prefer one over the other for neuropathic pain. It says the choice should fit the person, based on how they respond and what they can tolerate.

Both carry similar warnings about sedation, misuse and the need to change the dose slowly.